Cargando…
A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine
Yellow fever, a mosquito-borne flavivirus infection, is an important public health problem in Africa and Latin America. A Yellow Fever vaccine (YFV) was developed and tested in a study in India. This was a Phase I, open-label, randomized, controlled study where healthy adults received SII YFV intram...
Autores principales: | Desai, Sajjad, Anil, K., Potey, Anirudha Vyankatesh, Sindhu, Y., Grappi, Silvia, Lapini, Giulia, Manney, Satyaprasad, Tyagi, Parikshit, Montomoli, Emanuele, Poonawalla, Cyrus S., Kulkarni, Prasad S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763341/ https://www.ncbi.nlm.nih.gov/pubmed/36535976 http://dx.doi.org/10.1038/s41541-022-00595-6 |
Ejemplares similares
-
A cross-sectional study to assess the incompatible dietary behavior of patients suffering from skin diseases: A pilot study
por: Kulkarni, Meghana, et al.
Publicado: (2016) -
Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects
por: Gianchecchi, Elena, et al.
Publicado: (2022) -
Post-marketing safety surveillance of the rotavirus vaccine in India
por: Kang, Gagandeep, et al.
Publicado: (2023) -
Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali
por: Roy Chowdhury, Panchali, et al.
Publicado: (2015) -
Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV
por: Motta, Edwiges, et al.
Publicado: (2023)